FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

37552311000001106: Dolenio 500mg tablets (Alissa Healthcare Research Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Sep 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
361201000001119 Dolenio 500mg tablets (Alissa Healthcare Research Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
361221000001114 Dolenio 500mg tablets (Alissa Healthcare Research Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Is a Glucosamine sulphate 500mg tablets true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Is a Dolenio true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Has specific active ingredient Glucosamine sulfate true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dolenio 500mg tablets (Alissa Healthcare Research Ltd) 90 tablet Has AMP True Dolenio 500mg tablets (Alissa Healthcare Research Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start